Financial Performance - For the nine months ended December 31, 2020, the group's revenue was approximately HKD 58.8 million, a decrease of 20.7% compared to HKD 74.1 million for the same period in 2019[8]. - The group reported a net loss of approximately HKD 21.7 million for the nine months ended December 31, 2020, compared to a net loss of HKD 13.4 million for the same period in 2019, representing an increase in loss of 61.4%[8]. - The group's pre-tax loss was HKD 22.0 million, compared to HKD 13.2 million in the previous year, representing a deterioration of 66.5%[10]. - Total comprehensive loss for the period was HKD 21.7 million, compared to HKD 13.4 million in the previous year, indicating an increase of 61.4%[10]. - The basic loss per share for the period was HKD 2.72, compared to HKD 1.68 for the same period last year[10]. - The company recorded a pre-tax loss of HKD 31,061,000 for the nine months ended December 31, 2020, down from HKD 36,528,000 in the previous year[29]. - The company recorded a net loss of approximately HKD 21.7 million for the nine months ended December 31, 2020, compared to a net loss of HKD 13.4 million for the same period in 2019[41]. Revenue and Income - Revenue from treatment services for the nine months ended December 31, 2020, was HKD 56,527,000, a decrease of 20% compared to HKD 70,664,000 for the same period in 2019[25]. - Total revenue for the nine months ended December 31, 2020, was HKD 58,838,000, down 20.6% from HKD 74,110,000 in the previous year[25]. - Other income increased significantly to HKD 8.3 million from HKD 1.4 million, marking a growth of 487.2%[10]. - Government subsidies received during the nine months ended December 31, 2020, amounted to HKD 7,186,000, compared to zero in the same period of 2019[27]. - Other income increased to approximately HKD 8.3 million for the nine months ended December 31, 2020, from HKD 1.4 million in the same period in 2019, primarily due to government subsidies[46]. Costs and Expenses - The group's cost of goods sold was HKD 9.2 million, up from HKD 8.2 million in the same period last year, indicating a rise of 12.4%[10]. - Employee costs decreased to HKD 31.1 million from HKD 36.5 million, reflecting a reduction of 14.5%[10]. - The company’s total employee costs for the nine months ended December 31, 2020, were HKD 31,061,000, a decrease of 15.1% from HKD 36,528,000 in the previous year[29]. - Depreciation of property, plant, and equipment rose to HKD 8.9 million from HKD 6.0 million, an increase of 48.8%[10]. - The depreciation expense for property, plant, and equipment increased to approximately HKD 8.9 million for the nine months ended December 31, 2020, from HKD 6.0 million in the same period in 2019, due to new acquisitions[50]. - Rental and related expenses decreased to approximately HKD 1.0 million for the nine months ended December 31, 2020, from HKD 2.9 million in the same period in 2019, due to temporary closures and rent concessions related to COVID-19[49]. Dividend and Shareholder Information - The board of directors did not recommend any dividend distribution for the nine months ended December 31, 2020, consistent with the previous year[8]. - The company did not recommend any dividend distribution for the nine months ended December 31, 2020, consistent with the previous year[33]. - The major shareholders, Mr. Ye and Ms. Fu, each hold a 75% interest in the company through Equal Joy, which has 600,000,000 shares[65]. - The company has adopted a share option scheme to attract and reward eligible individuals for their contributions, which is valid for ten years unless terminated by shareholders[71]. - As of December 31, 2020, there were no outstanding share options or convertible securities issued under the share option scheme[73]. Operational Impact and Future Outlook - The company temporarily closed its medical beauty centers for a total of 94 days due to COVID-19, significantly impacting revenue[41]. - The company remains optimistic about the medical beauty service industry despite the challenges posed by COVID-19 and is committed to maximizing shareholder value[43]. - The company expanded its operations by opening new centers in Central, Causeway Bay 2, and Tsim Sha Tsui 2 to capture growing customer demand[41]. - The company plans to enhance its service offerings and expand its training programs for laser and light beauty treatments recognized by the Hong Kong Qualifications Framework[41]. Compliance and Governance - The company has adopted the corporate governance code as per GEM Listing Rules Appendix 15 and has complied with all applicable provisions during the reporting period[56]. - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited consolidated results for the nine months ended December 31, 2020, and found them to comply with applicable accounting standards and legal requirements[59]. - No shares of the company were purchased, sold, or redeemed by the company or any of its subsidiaries during the nine months ended December 31, 2020[60]. - The company changed its compliance advisor from Chuangshing Financing Limited to Sky Capital Limited effective May 9, 2020, due to a consensus not being reached on fee levels[61]. - No arrangements were made for directors to acquire shares or debt securities of the company during the nine months ending December 31, 2020[74]. - No directors or their associates engaged in any business that directly or indirectly competes with the group's business during the nine months ending December 31, 2020[75]. - The executive directors as of the report date include Mr. Ye Zhen Guo and Ms. Fu Zhi Qing[76].
亮晴控股(08603) - 2021 Q3 - 季度财报